Stuart Gibb

Scientific Strategy Lead • Terumo Blood and Cell Technologies

Stuart has an unapologetic passion for Cell therapies. Educated with a Ph.D from Cambridge University in Neuroscience, Stuart has investigated several neurodegenerative disorders and evolved his interests from discovery research to interventional cell and gene therapies.  Stuart has spent the last 10 years employing hollow-fiber bioreactors to unmet medical needs from the culture of MSCs, to exosome and viral vectors generation and also suspension cells expansion

Also Speaking

Craig Hasilo

Jennifer Collins

Principal, Apheresis and Infusion Specialist • Vertex Cell and Gene Therapies

Olivier Negre

Chief Scientific Officer • Smart-Immune

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.